Works matching IS 14642662 AND DT 2015 AND VI 16 AND IP 6

Results: 10

Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada.

Published in:

2015

By:

Lourenço, L;
Samji, H;
Nohpal, A;
Chau, W;
Colley, G;
Lepik, K;
Barrios, R;
Lima, V;
Hogg, Rs;
Montaner, Jsg;
Kesselring, S;
Moore, Dm

Publication type:

Journal Article

Treatment initiation factors and cognitive outcome in youth with perinatally acquired HIV infection.

Published in:

HIV Medicine, 2015, v. 16, n. 6, p. 355, doi. 10.1111/hiv.12220

By:

Lazarus, J Rutstein;
Rutstein, RM;
Lowenthal, ED

Publication type:

Article

Contraceptive options for HIV-positive women: making evidence-based, patient-centred decisions.

Published in:

HIV Medicine, 2015, v. 16, n. 6, p. 329, doi. 10.1111/hiv.12221

By:

Sharma, M;
Walmsley, SL

Publication type:

Article

Early glial activation precedes neurodegeneration in the cerebral cortex after SIV infection: A 3D, multivoxel proton magnetic resonance spectroscopy study.

Published in:

HIV Medicine, 2015, v. 16, n. 6, p. 381, doi. 10.1111/hiv.12222

By:

Wu, WE;
Babb, JS;
Tal, A;
Kirov, II;
George, AE;
Ratai, E‐M;
Gonzalez, RG;
Gonen, O

Publication type:

Article

The rapid test in Spanish pharmacies: a novel programme to reach heterosexual men?

Published in:

HIV Medicine, 2015, v. 16, n. 6, p. 362, doi. 10.1111/hiv.12224

By:

Fernández‐Balbuena, S;
Marcos, H;
Pérez‐Rubio, A;
Hoyos, J;
Belza, MJ;
Fuente, L

Publication type:

Article

Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.

Published in:

HIV Medicine, 2015, v. 16, n. 6, p. 388, doi. 10.1111/hiv.12243

By:

Tiraboschi, JM;
Muñoz‐Moreno, JA;
Puertas, MC;
Alonso‐Villaverde, C;
Prats, A;
Ferrer, E;
Rozas, N;
Maso, M;
Ouchi, D;
Martinez‐Picado, J;
Podzamczer, D

Publication type:

Article

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

Published in:

HIV Medicine, 2015, v. 16, n. 6, p. 370, doi. 10.1111/hiv.12210

By:

Martínez, E;
Ribera, E;
Clotet, B;
Estrada, V;
Sanz, J;
Berenguer, J;
Rubio, R;
Pulido, F;
Larrousse, M;
Curran, A;
Negredo, E;
Arterburn, S;
Ferrer, P;
Álvarez, ML

Publication type:

Article

Hyperferritinemia and markers of inflammation and oxidative stress in the cord blood of HIV-exposed, uninfected ( HEU) infants.

Published in:

HIV Medicine, 2015, v. 16, n. 6, p. 375, doi. 10.1111/hiv.12214

By:

Selvam, A;
Buhimschi, IA;
Makin, JD;
Pattinson, RC;
Anderson, R;
Forsyth, BW

Publication type:

Article

Impact of defined clinical population and missing data on temporal trends in HIV viral load estimation within a health care system.

Published in:

HIV Medicine, 2015, v. 16, n. 6, p. 346, doi. 10.1111/hiv.12219

By:

Edelman, EJ;
Tate, JP;
Fiellin, DA;
Brown, ST;
Bryant, K;
Gandhi, N;
Gibert, CL;
Goetz, MB;
Gordon, KS;
Rodriguez‐Barradas, MC;
Braithwaite, RS;
Rimland, D;
Justice, AC

Publication type:

Article

Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada.

Published in:

HIV Medicine, 2015, v. 16, n. 6, p. 337, doi. 10.1111/hiv.12212

By:

Lourenço, L;
Samji, H;
Nohpal, A;
Chau, W;
Colley, G;
Lepik, K;
Barrios, R;
Lima, V;
Hogg, RS;
Montaner, JSG;
Kesselring, S;
Moore, DM

Publication type:

Article